Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced Modulus ...

Last month, Globus Medical announced a definitive agreement to acquire Nevro Corp. in an all-cash transaction valued at approximately $250 million. The transaction enables the company to expand ...

In this article, we are going to take a look at where Globus Medical, Inc. (NYSE:GMED) stands against the other medical technology stocks. Growth and Drivers of the Global MedTech Market The MedTech ...

Globus Medical, Inc. reported $657,293 million in sales and $60,275 million in operating profit for the quarter ending December 31, 2024, which was above both Wall Street’s expectations and management ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Globus Medical (GMED – Research Report). The ...

Truist analyst Richard Newitter lowered the firm’s price target on Globus Medical (GMED) to $82 from $90 and keeps a Hold rating on the shares.